LC-MS/MS comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-10-11. Numbers and descriptions here follow the published literature rather than marketing material.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow solid | Visual description varies with purity and source |
| Solubility | Soluble in DMSO and ethanol; poorly soluble in water | Organic stock solutions are common in research |
| Typical storage | -20 °C, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Typical analytical method | LC-MS or HPLC-UV | Reference standards are needed for quantification |
| Molar mass | Approximately 437.9 g/mol | Calculated from the reported free-base formula |
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
=== The last thirteen === Meanwhile, the American team had created seaborgium, and the next six elements had been created by a German team: bohrium, hassium, meitnerium, darmstadtium, roentgenium, and copernicium. Element 113, nihonium, was created by a Japanese team; the last five known elements, flerovium, moscovium, livermorium, tennessine, and oganesson, were created by Russian–American collaborations and complete the seventh row of the periodic table.
== Related compounds == A dual DOR and κ-opioid receptor (KOR) PAM, BMS-986187, derived from BMS-986122, has been developed and is selective for these receptors over the MOR. Another MOR PAM with a simpler synthesis, MS1, was subsequently developed and has shown similar effects to those of BMS-986122. Additionally, ignavine, a natural MOR PAM found in Aconitum, has also been identified. In 2024, ketamine and its metabolites norketamine and hydroxynorketamine (HNK) were identified as highly potent MOR, DOR, and KOR PAMs (active at a concentration of as low as 1 nM). These actions were implicated in their potential antidepressant and analgesic effects.
The area returned to the English crown in 1157, when Henry II of England took possession of the area (from Malcolm IV of Scotland). Henry II formed two new counties from the former earldom: Westmorland and Carliol – originally an abbreviation of the Latin Carlioliensis '[bishop] of Carlisle'. Westmorland also included areas formerly part of the Earldom of Lancaster. The lead- and silver-mining area of Alston, previously associated with the Liberty of Tynedale was later also added to the new county of Carliol for financial reasons. By 1177, Carliol had become known as Cumberland. The border between England and Scotland was made permanent by the Treaty of York in 1237. The population of Cumberland in the 1841 census was 178,038.
== Terminology == "Redox" is a portmanteau of "reduction" and "oxidation". The term first appeared in a 1928 article by Leonor Michaelis and Louis B. Flexner. Oxidation is a process in which a substance loses electrons. Reduction is a process in which a substance gains electrons. The processes of oxidation and reduction occur simultaneously and cannot occur independently. In redox processes, the reductant transfers electrons to the oxidant. Thus, in the reaction, the reductant or reducer or reducing agent loses electrons and is oxidized, while the oxidant or oxidizer or oxidizing agent gains electrons and is reduced. The pair of an oxidizing and reducing agent that is involved in a particular reaction is called a redox pair. A redox couple is a reducing species and its corresponding oxidizing form, e.g., Fe2+/ Fe3+.The oxidation alone and the reduction alone are each called a half-reaction because two half-reactions always occur together to form a whole reaction. In electrochemical reactions the oxidation and reduction processes do occur simultaneously but are separated in space. Although oxidation is commonly associated with forming oxides, other chemical species can serve the same function; in hydrogenation, bonds such as C=C are reduced by the transfer of hydrogen atoms.
==== Monetary policy ==== Since Castillo's victory in the first electoral round, the Sol has faced a precipitous fall in value against the dollar, due to fears of inflation and expropriations. As of 23 September 2021, the Sol had lost 12% of its value since the start of the year, making Peru's currency one of the worst performers among emerging markets. Castillo has sought to calm the markets by keeping Julio Velarde as the head of the Central Bank. During a speech before the OAS assembly, Castillo stated that his government is not communist and that he wouldn't expropriate anyone. Castillo stated that he didn't come to scare away investment, and invited big businesses to come to the country. Following Bellido's threat to nationalize the Camisea gas fields, the sol plunged once again. Afterward, Castillo replaced the Bellido cabinet with the Vásquez cabinet, which many have seen as a shift towards a more centrist administration. Following the new cabinet, the Sol began to recover its value, reaching a 10-week high as of 13 October 2021. However, after Castillo asked Congress to nationalize the Camisea gas fields, the Sol began to fall in value once again. On 9 November 2021, the Bank of America warned that almost all of Peru's inflation indicators are on red alert. They claimed that Peru's expectations "are set to exceed the upper limit of 3% of the Central Bank's target range of a two-year term." The Bank of America suggested that the Central Bank will have to tighten monetary policy.
Sources: en.wikipedia.org
=== Administrative work === In 1959, after offering advice to Yale president A. Whitney Griswold on strengthening the sciences at Yale, Fruton became director of the division of science, a position he held until 1962. His work led to the creation of the short-lived department of molecular biology and biophysics (MBB), although his initial proposal to create a similar department that combined the existing biophysics and biochemistry departments was rejected. Fruton became burnt out on Yale politics after an extended conflict with provost Kingman Brewster, in which Brewster attempted to bypass Fruton's science advisory committee and create a molecular biology department independent of biochemistry department; the MBB department was created only after Brewster had failed to attract a prominent scientist from outside Yale to head a molecular biology department, and the department of biochemistry remained separate as part of the medical school until the creation of the department of molecular biophysics & biochemistry (MB&B) in 1969 (which was itself created after a lengthy and unsuccessful attempt to find a suitably eminent replacement for Fruton to head the department of biochemistry). Fruton was elected to the American Philosophical Society in 1968.
== Production == The production of a proper theriac took months with all the collection and fermentation of herbs and other ingredients. It was supposed to be left to mature for years. As a result, it was also expensive and hence available only for the rich. According to the commentary on Exodus, Ki Tisa, the Spanish scholar Moses ben Nachman lists the ingredients of theriac as leaven, honey, flesh of wild beasts and reptiles, dried scorpion and viper. According to Galen, theriac reached its greatest potency six years after preparation and kept its virtues for 40 years. It was therefore good practice to make large batches; in 1712, 150 kg of theriac was prepared at one session in Maastricht in the Netherlands. By the time of the Renaissance, the making of theriac had become an official ceremony, especially in Italy. In Italy, pharmacists sold it as late as 1930.
Gallium (68Ga) gozetotide or Gallium (68Ga) PSMA-11, is a radiopharmaceutical made of 68Ga conjugated to a inhibitor of the enzyme prostate-specific membrane antigen (PSMA) known as Glu-Urea-Lys(Ahx)-HBED-CC. It is used for imaging prostate cancer by positron emission tomography (PET). The PSMA inhibitor specifically directs the radiolabeled imaging agent towards the prostate cancerous lesions in men. The most common side effects with gallium (68Ga)-radiolabelled gozetotide are tiredness, nausea (feeling sick), constipation and vomiting. Gallium (68Ga) gozetotide was approved for medical use in the United States in December 2021, and in the European Union in December 2022. It is the first drug approved by the US Food and Drug Administration (FDA) as a PET imaging agent of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.
[H3SO4]+[HSO4]− = 2.7 × 10−4 The corresponding equilibrium constant for water, Kw is 10−14, a factor of 1010 (10 billion) smaller. In spite of the viscosity of the acid, the effective molar conductivities of the H3SO+4 and HSO−4 ions are high due to an intramolecular proton-switch mechanism (analogous to the Grotthuss mechanism in water), making sulfuric acid a good conductor of electricity.
== Symbols == A few symbols are in current use in botany. A number of others are obsolete; for example, Linnaeus used planetary symbols ⟨♂⟩ (Mars) for biennial plants, ⟨♃⟩ (Jupiter) for herbaceous perennials and ⟨♄⟩ (Saturn) for woody perennials, based on the planets' orbital periods of 2, 12 and 30 years; and Willd used ⟨♄⟩ (Saturn) for neuter in addition to ⟨☿⟩ (Mercury) for hermaphroditic. The following symbols are still used:
Sources: en.wikipedia.org
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.
The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.
Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.